Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria

Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria

Abstract Background Chimeric antigen receptor T-cell therapy (CART) prolongs survival for patients with refractory or relapsed lymphoma. Discrepancies among different response criteria for lymphoma under CART were recently shown. Our objective was to evaluate reasons for discordance among different...

Full description

Bibliographic Details
Main Authors: Michael Winkelmann, Viktoria Blumenberg, Kai Rejeski, Veit L. Bücklein, Maria Ingenerf, Marcus Unterrainer, Christian Schmidt, Franziska J. Dekorsy, Peter Bartenstein, Jens Ricke, Michael von Bergwelt-Baildon, Marion Subklewe, Wolfgang G. Kunz
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Cancer Imaging
Subjects:
CAR T-cell therapy
18F-FDG PET/CT
Lugano criteria
Cheson
RECIL
LYRIC
Online Access:https://doi.org/10.1186/s40644-023-00566-7

Internet

https://doi.org/10.1186/s40644-023-00566-7

Similar Items